Your browser doesn't support javascript.
loading
The METRO study: a retrospective analysis of the efficacy of metformin for type 2 diabetes in Japan.
Harada, Marina; Kondo, Yoshinobu; Sugiyama, Mai; Ohira, Akeo; Ichikawa, Masahiro; Akiyama, Tomoaki; Orime, Kazuki; Takai, Takanori; Yamakawa, Tadashi; Terauchi, Yasuo.
Affiliation
  • Harada M; Department of Endocrinology and Diabetes, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
  • Kondo Y; Tsunashima East Internal Medicine and Diabetes Clinic, Yokohama 223-0052, Japan.
  • Sugiyama M; Department of Endocrinology and Diabetes, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
  • Ohira A; Department of Endocrinology and Diabetes, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
  • Ichikawa M; Department of Endocrinology and Diabetes, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
  • Akiyama T; Department of Endocrinology and Diabetes, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
  • Orime K; Department of Endocrinology and Diabetes, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
  • Takai T; Urafune Kanazawa Internal Medicine Clinic, Yokohama 232-0024, Japan.
  • Yamakawa T; Department of Endocrinology and Diabetes, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
  • Terauchi Y; Department of Endocrinology and Metabolism, Yokohama City University School of Medicine, Yokohama 236-0004, Japan.
Endocr J ; 70(1): 121-128, 2023 Jan 30.
Article in En | MEDLINE | ID: mdl-36261368

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Metformin Type of study: Risk_factors_studies Limits: Humans / Middle aged Country/Region as subject: Asia Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Metformin Type of study: Risk_factors_studies Limits: Humans / Middle aged Country/Region as subject: Asia Language: En Year: 2023 Type: Article